FIELD: medicine.
SUBSTANCE: medications containing hydroxyapatite and active components for transcutaneous and/or transmucous delivery are claimed. Maximum size of hydroxyapatite particles is 1 mcm or less, preferably 0.1 mcm or less, and hydroxyapatite content included in composition comprises 0.1 to 1000 wt % of medication weight.
EFFECT: excellent amplification effect on transcutaneous and/or transmucous suction of active components applied onto skin or mucosa.
24 cl, 11 tbl, 15 ex
| Title | Year | Author | Number |
|---|---|---|---|
| INTENSIFIER OF PERCUTANEOUS SUCTION AND TRANSDERMAL MEDICATION WITH ITS APPLICATION | 2009 |
|
RU2504363C2 |
| METHOD OF INCREASING WATER SOLUBILITY OF LOW-SOLUBILITY SUBSTANCES | 2010 |
|
RU2517111C2 |
| SUITABLE FOR DISPERSION ADHESIVE TO SKIN/MUCOUS MEMBRANE GEL-TYPE MEDICATION, AND SYSTEM FOR INTRODUCTION WITH MEDICATION APPLICATION | 2007 |
|
RU2438710C2 |
| TRANSCUTANEOUS SUCTION COMPOSITION | 2016 |
|
RU2702356C2 |
| IMPROVING ABSORPTION OF THERAPEUTIC AGENTS THROUGH MUCOUS MEMBRANES OR SKIN | 2009 |
|
RU2519193C2 |
| COMPOSITION FOR TRANSCUTANEOUS ABSORPTION | 2007 |
|
RU2435570C2 |
| EXTERNAL AND LOCAL PHARMACEUTICAL STEPHAGLABRIN PREPARATION | 2007 |
|
RU2364399C1 |
| LOCAL AND EXTERNAL PHARMACEUTICAL PRODUCT BASED OF LOW MOLECULAR INTERFERON INDUCER | 2007 |
|
RU2353354C1 |
| TRANSCUTANEOUS PATCH WITH MICRONEEDLES CONTAINING DONEPEZIL | 2018 |
|
RU2735835C1 |
| POWDER PHARMACEUTICAL FORM FOR RELIEF ACCELERATION OF OSTEOMYELITIS CONTAINING CHLORIDE RUBIDIUM | 2018 |
|
RU2668692C1 |
